Chronic Lymphoid Leukemia PB CD19+/CD5+ B Cells (Newly Diagnosed/Untreated)

Cat.No.: CSC-C4556X

Species: Human

Source: Blood

Cell Type: B

  • Specification
  • Q & A
  • Customer Review
Cat.No.
CSC-C4556X
Description
Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages.
The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.
Species
Human
Source
Blood
Cell Type
B
Disease
Diseased
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Ask a Question

Write your own review

For research use only. Not for any other purpose.